Ana Velosa

Disease Spotlight

When faced with a devastating diagnosis, a family has two choices – to give up or make it their mission to adapt and carry on.

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.